Carlos Rodríguez-Pascual
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Carlos Rodríguez-Pascual has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:
- Emilio Paredes-Galán
Cardiology Department, Complejo Hospitalario Universitario de Vigo, Spain
8 shared publications Fernando Rodríguez-Artalejo
Department of Preventive Medicine and Public Health, Universidad Autónoma de Madrid /IdiPaz, CIBERESP, and IMDEA-Food Institute, Madrid, Spain
7 shared publications- Pilar Guallar-Castillón
Department of Preventive Medicine and Public Health, School of Medicine, Universidad Autónoma de Madrid, 28029 Madrid, Spain
7 shared publications - Arturo Vilches-Moraga
University of Manchester
5 shared publications - Fernando Rodríguez-Artalejo
Department of Preventive Medicine and Public Health, Universidad Autónoma de Madrid, 28029 Madrid, Spain
5 shared publications José R. Banegas
Department of Preventive Medicine and Public Health; CIBER of Epidemiology and Public Health (CIBERESP), Universidad Autónoma de Madrid; Idipaz; , Madrid
4 shared publications
Latest Publications
- 1 November 2018
- Published by Elsevier in Journal of the American Medical Directors Association
- Vol. 19 (11) , 936-941
Safety of Direct Oral Anticoagulants and Vitamin K Antagonists in Oldest Old Patients: A Prospective Study
- 1 November 2018
- Published by Elsevier in Journal of the American Medical Directors Association
- Vol. 19 (11) , 936-941
Safety of Direct Oral Anticoagulants and Vitamin K Antagonists in Oldest Old Patients: A Prospective Study
- 11 October 2018
- Published by Elsevier in Revista Española de Geriatría y Gerontología
- Vol. 53 (6) , 311-313
Anticoagulantes orales en pacientes frágiles con fibrilación auricular: moviéndose en la incertidumbre en la práctica clínica diaria
- 11 October 2018
- Published by Elsevier in Revista Española de Geriatría y Gerontología
- Vol. 53 (6) , 311-313
Anticoagulantes orales en pacientes frágiles con fibrilación auricular: moviéndose en la incertidumbre en la práctica clínica diaria
- 8 July 2018
- Published by Elsevier in Revista Española de Cardiología (English Edition)
- Vol. 72 (5) , 392-397
Prognosis of Patients With Severe Aortic Stenosis After the Decision to Perform an Intervention
- 8 July 2018
- Published by Elsevier in Revista Española de Cardiología (English Edition)
- Vol. 72 (5) , 392-397
Prognosis of Patients With Severe Aortic Stenosis After the Decision to Perform an Intervention
- Top Cited PapersOpen Access
The Changing Landscape for Stroke Prevention in AF
- 1 December 2016
- Published by Elsevier in International Journal of Cardiology
- Vol. 224, 125-131
The frailty syndrome and mortality among very old patients with symptomatic severe aortic stenosis under different treatments
- 1 December 2016
- Published by Elsevier in International Journal of Cardiology
- Vol. 224, 125-131
The frailty syndrome and mortality among very old patients with symptomatic severe aortic stenosis under different treatments
- 1 July 2016
- Published by Elsevier in The American Journal of Cardiology
- Vol. 118 (2) , 244-250
Comparison of 1-Year Outcome in Patients With Severe Aorta Stenosis Treated Conservatively or by Aortic Valve Replacement or by Percutaneous Transcatheter Aortic Valve Implantation (Data from a Multicenter Spanish Registry)
- 1 July 2016
- Published by Elsevier in The American Journal of Cardiology
- Vol. 118 (2) , 244-250
Comparison of 1-Year Outcome in Patients With Severe Aorta Stenosis Treated Conservatively or by Aortic Valve Replacement or by Percutaneous Transcatheter Aortic Valve Implantation (Data from a Multicenter Spanish Registry)
- 1 June 2015
- Published by Elsevier in International Journal of Cardiology
- Vol. 189, 61-66
Comorbidity and intervention in octogenarians with severe symptomatic aortic stenosis
- 1 June 2015
- Published by Elsevier in International Journal of Cardiology
- Vol. 189, 61-66
Comorbidity and intervention in octogenarians with severe symptomatic aortic stenosis
- 1 March 2014
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 7 (2) , 251-258
Comprehensive Geriatric Assessment and 2-Year Mortality in Elderly Patients Hospitalized for Heart Failure
Background—: In older adults hospitalized for heart failure, a poor score on a comprehensive geriatric assessment (CGA) is associated with worse prognosis during hospitalization and at 1 month after discharge. However, the association between the CGA score and long-term mortality is uncertain. Methods and Results—: This is a prospective study of 487 patients aged ≥75 years admitted for decompensated heart failure. At discharge, a CGA score (range, 0–10) was calculated based on limitation in activities of daily living, mobility limitation, comorbidity, cognitive decline, and previous medication use. The analysis of the association between the CGA score and 2-year subsequent mortality was performed with Cox regression and adjusted for the main confounders. A 1-point increase in the CGA score was associated with a 19% higher mortality (hazard ratio, 1.19; 95% confidence interval, 1.11–1.27). Results were similar regardless of age, sex, left ventricular ejection fraction, and the coexistence of atrial fibrillation, ischemic heart disease, or hypertensive cardiopathy. All components of the CGA score showed a consistent association with higher death risk: the hazard ratio (95% confidence interval) of mortality was 1.78 (1.25–2.54) with ≥3 versus 0 limitations in activities of daily living, 1.36 (1.0–1.86) with moderate or severe versus no or mild limitation in mobility, 1.98 (1.29–3.03) with a ≥5 versus ≤1 score on the Charlson index, 2.48 (1.84–3.34) with previous cognitive decline, and 1.77 (0.99–3.18) in those using ≥8 versus ≤3 medications. Conclusions—: The score on a simple CGA is associated with long-term mortality in older patients hospitalized for heart failure.
- 1 March 2014
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 7 (2) , 251-258
Comprehensive Geriatric Assessment and 2-Year Mortality in Elderly Patients Hospitalized for Heart Failure
Background—: In older adults hospitalized for heart failure, a poor score on a comprehensive geriatric assessment (CGA) is associated with worse prognosis during hospitalization and at 1 month after discharge. However, the association between the CGA score and long-term mortality is uncertain. Methods and Results—: This is a prospective study of 487 patients aged ≥75 years admitted for decompensated heart failure. At discharge, a CGA score (range, 0–10) was calculated based on limitation in activities of daily living, mobility limitation, comorbidity, cognitive decline, and previous medication use. The analysis of the association between the CGA score and 2-year subsequent mortality was performed with Cox regression and adjusted for the main confounders. A 1-point increase in the CGA score was associated with a 19% higher mortality (hazard ratio, 1.19; 95% confidence interval, 1.11–1.27). Results were similar regardless of age, sex, left ventricular ejection fraction, and the coexistence of atrial fibrillation, ischemic heart disease, or hypertensive cardiopathy. All components of the CGA score showed a consistent association with higher death risk: the hazard ratio (95% confidence interval) of mortality was 1.78 (1.25–2.54) with ≥3 versus 0 limitations in activities of daily living, 1.36 (1.0–1.86) with moderate or severe versus no or mild limitation in mobility, 1.98 (1.29–3.03) with a ≥5 versus ≤1 score on the Charlson index, 2.48 (1.84–3.34) with previous cognitive decline, and 1.77 (0.99–3.18) in those using ≥8 versus ≤3 medications. Conclusions—: The score on a simple CGA is associated with long-term mortality in older patients hospitalized for heart failure.
- Open Access
- 9 December 2013
- Published by Wiley in Journal of Internal Medicine
- Vol. 275 (6) , 608-620
Prospective registry of symptomatic severe aortic stenosis in octogenarians: a need for intervention
Objective: To study the factors associated with choice of therapy and prognosis in octogenarians with severe symptomatic aortic stenosis (AS).Study Design: Prospective, observational, multicenter registry. Centralized follow‐up included survival status and, if possible, mode of death and Katz index.Setting: Transnational registry in Spain.Subjects: We included 928 patients aged ≥80 years with severe symptomatic AS.Interventions: Aortic‐valve replacement (AVR), transcatheter aortic‐valve implantation (TAVI) or conservative therapy.Main outcome measures: All‐cause death.Results: Mean age was 84.2 ± 3.5 years, and only 49.0% were independent (Katz index A). The most frequent planned management was conservative therapy in 423 (46%) patients, followed by TAVI in 261 (28%) and AVR in 244 (26%). The main reason against recommending AVR in 684 patients was high surgical risk [322 (47.1%)], other medical motives [193 (28.2%)], patient refusal [134 (19.6%)] and family refusal in the case of incompetent patients [35 (5.1%)]. The mean time from treatment decision to AVR was 4.8 ± 4.6 months and to TAVI 2.1 ± 3.2 months, P < 0.001. During follow‐up (11.2–38.9 months), 357 patients (38.5%) died. Survival rates at 6, 12, 18 and 24 months were 81.8%, 72.6%, 64.1% and 57.3%, respectively. Planned intervention, adjusted for multiple propensity score, was associated with lower mortality when compared with planned conservative treatment: TAVI Hazard ratio (HR) 0.68 (95% confidence interval [CI] 0.49–0.93; P = 0.016) and AVR HR 0.56 (95% CI 0.39–0.8; P = 0.002).Conclusion: Octogenarians with symptomatic severe AS are frequently managed conservatively. Planned conservative management is associated with a poor prognosis.
- 9 December 2013
- Published by Wiley in Journal of Internal Medicine
- Vol. 275 (6) , 608-620
Open AccessProspective registry of symptomatic severe aortic stenosis in octogenarians: a need for intervention
Objective: To study the factors associated with choice of therapy and prognosis in octogenarians with severe symptomatic aortic stenosis (AS).Study Design: Prospective, observational, multicenter registry. Centralized follow‐up included survival status and, if possible, mode of death and Katz index.Setting: Transnational registry in Spain.Subjects: We included 928 patients aged ≥80 years with severe symptomatic AS.Interventions: Aortic‐valve replacement (AVR), transcatheter aortic‐valve implantation (TAVI) or conservative therapy.Main outcome measures: All‐cause death.Results: Mean age was 84.2 ± 3.5 years, and only 49.0% were independent (Katz index A). The most frequent planned management was conservative therapy in 423 (46%) patients, followed by TAVI in 261 (28%) and AVR in 244 (26%). The main reason against recommending AVR in 684 patients was high surgical risk [322 (47.1%)], other medical motives [193 (28.2%)], patient refusal [134 (19.6%)] and family refusal in the case of incompetent patients [35 (5.1%)]. The mean time from treatment decision to AVR was 4.8 ± 4.6 months and to TAVI 2.1 ± 3.2 months, P < 0.001. During follow‐up (11.2–38.9 months), 357 patients (38.5%) died. Survival rates at 6, 12, 18 and 24 months were 81.8%, 72.6%, 64.1% and 57.3%, respectively. Planned intervention, adjusted for multiple propensity score, was associated with lower mortality when compared with planned conservative treatment: TAVI Hazard ratio (HR) 0.68 (95% confidence interval [CI] 0.49–0.93; P = 0.016) and AVR HR 0.56 (95% CI 0.39–0.8; P = 0.002).Conclusion: Octogenarians with symptomatic severe AS are frequently managed conservatively. Planned conservative management is associated with a poor prognosis.